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Abstract: We have demonstrated label free detection of CD4+ and CD8+ T-Lymphocyte 
whole  cells  and  CD4+  T-Lymphocyte  cell  lysis  using  the  optofluidic  ring  resonator 
(OFRR) sensor. The OFRR sensing platform incorporates microfluidics and photonics in a 
setup that utilizes small sample volume and achieves a fast detection time. In this work, 
white blood cells were isolated from healthy blood and the concentrations were adjusted to 
match T-Lymphocyte levels of individuals infected with HIV. Detection was accomplished 
by immobilizing CD4 and CD8 antibodies on the inner surface of the OFRR. Sensing 
results  show  excellent  detection  of  CD4+  and  CD8+  T-Lymphocyte  cells  at  medically 
significant concentrations with a detection time of approximately 30 minutes. This work 
will lead to a rapid and low-cost sensing device that can provide a CD4 and CD8 count as a 
measure of HIV progression. 
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1. Introduction 
The ability to detect and quantify HIV infection is essential to physicians seeking to maximize the 
impact of treatment and accuracy of prognosis. One way to achieve this is to look at the counts of 
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CD4+ T-Lymphocyte cells as biological indictors of the progression of HIV [1]. Normal CD4+ counts 
in healthy individuals are around 1,200 CD4+ cells per µL [2-4]. Infected individuals usually begin 
Highly Active Anti-Retroviral Treatment (HAART) when CD4+ concentration levels drop into the 
range of 200 to 300 CD4+ cells per µL and are diagnosed as having AIDS when these counts fall 
below 200 CD4+ cells per µL. HAART can be initiated at higher CD4+ counts (300–800 CD4+ cells 
per µ L) if it is deemed necessary by the physician [3-7]. 
Another test that may be used in conjunction with a CD4+ count is the CD8+ T-Lymphocyte count, 
which might be able to assess the risk of rapid CD4+ cell depletion and susceptibility to developing 
AIDS [8-10]. CD8+ levels typically rise as HIV infection progresses [9,11]. In a healthy individual 
there are normally 1–2 CD4+ cells to every 1 CD8+ cell. This number can be expressed as a ratio of 
CD4+/CD8+. As this ratio decreases, it may be a sign that the immune system is becoming weaker and 
more prone to opportunistic infection [9,11]. It has been suggested that after CD4+ counts fall below 
the AIDS threshold CD8+ cell levels will begin to drop from an elevated level [9,12]. Monitoring these 
falling CD8+ cell levels late in HIV infection can give doctors a measure of virus severity and tools for 
a more accurate prognosis [9,11,12]. 
Presently, CD4+ and CD8+ counts can be accurately established in a clinical setting using a flow 
cytometer  [7,13].  These  machines  work  by  labeling  CD4+  or  CD8+  receptors  with  fluorescent 
antibodies  and  counting  the  resulting  fluorescent  signal.  While  flow  cytometers  accomplish  these 
counts with great accuracy and high throughput, they have intrinsic limitations such as high equipment 
cost, the need for specialized personnel, and high maintenance requirements [13]. These setbacks make 
such equipment unusable in under-developed countries where HIV has reached pandemic levels. In 
these countries there is a great need for devices that can detect CD4+ and CD8+ counts as a measure of 
HIV progression in a rapid, easy to use, and low cost setup. 
In the past few years there have been many studies related to CD4+ cell detection focusing on 
developing low cost CD4+ detection alternatives that perform well compared to established detection 
technologies  [1].  One  method  that  is  being  heavily  researched  to  improve  the  ease  and  size 
requirements of detection is combining quantum dot (QD) fluorescent technology with lab on a chip 
based  bio-detection  platforms  [14].  Properties  such  as  photostability  and  ease  of  capturing  target 
receptors make  QDs  optimal for imaging target molecules in a small  setup [14]. Another method 
recently studied for CD4 cell detection uses cell affinity chromatography in a microfluidic chip based 
platform [3]. This technology relies on fluorescent labeling of cells captured by a differential shear 
flow  in  a  microfluidic  channel  specifically  calibrated  for  CD4  isolation  [3].  Expanding  upon  
lab-on-a-chip based platforms, devices utilizing metal oxide semiconducting field effect transistors 
(MOSFETs) to obtain fast CD4+ cell counts and fluorescent technologies to verify cell concentrations 
have also been demonstrated [15]. While these methods show promise, the technologies rely heavily on 
fluorescent tagging and imaging to achieve detection. These labeling procedures add to the complexity 
of  the  detection  mechanism  by  requiring  expensive  QDs,  fluorescent  labels,  and  imaging  
equipment [3].  
In this work we have developed an optofluidic ring resonator (OFRR) sensor for label free detection 
of CD4+ and CD8+ T-Lymphocyte whole cells and CD4+ T-Lymphocyte cell lysis that addresses some 
of  the  weaknesses  described  above.  The  OFRR  is  an  optical  sensing  platform  that  integrates Sensors 2010, 10                                       
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mircofluidics with an optical ring resonator technology [16]. Shown in Figure 1, a tapered fiber cable 
couples light into the capillary wall where it is confined in circular resonances known as whispering 
gallery modes (WGMs). When the input light matches the resonant condition of the WGM, a dip in 
light intensity is observed at the end of the tapered fiber cable. The spectral position of this mode can 
be used to track the sensing signal in real time. While the WGM is resonating, an evanescent field will 
extend about 100 nm from the inner capillary interface. Because of this, the glass wall of the OFRR 
needs to be thin enough (<4 µm) to allow an evanescent field to extend into the microfluidic channel 
and interact with analyte. 
Figure 1. Schematic of the OFRR, sensing signal and experimental setup for cell detection. 
 
 
OFRR  devices  achieve  label  free sensing by detecting the refractive index (RI) changes  in  the 
microfluidic channel. This change in RI can be caused by a change in the overall fluid in the core or a 
buildup of biomolecules on the surface of the channel. The relationship between the spectral shift of 
the WGM and the RI of the microfluidic core is shown mathematically by [17-19]: 
lλ = 2πreffneff  (1)  
where neff is the effective RI of the solution sensed by the WGMs, reff is the radius of the capillary, l is 
an integer representing the angular momentum of the WGM, and λ is the resonant wavelength of the 
WGM. As biomolecules bind to the inner surface of the OFRR’s microfluidic channel, they interact 
with  the  evanescent  field.  The  accumulation  of  a  biomolecule  layer  changes  the  neff,  leading  to 
measurable change in λ due to a WGM resonant wavelength shift. The OFRR has been used to detect 
protein [19], DNA [20], viral particle [18], and pesticide concentrations [21] with a RI detection limit 
on  the  order  of  10
−7  refractive  index  units  (RIU)  and  mass  detection  on  the  order  of  
pg mm
−2 [16,18,20-22]. Sensors 2010, 10                                       
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In addition to excellent performance, the OFRR has several essential properties that make it an easy 
to use and low cost alternative for CD4+ and CD8+ detection. The use of mature telecom optical 
equipment contributes to the low cost of the overall setup and availability of setup components. Having 
the ring resonator incorporated with a microfluidic channel that is only a hundred micrometers in 
diameter provides a small device size that uses a very small sample to achieve detection and a short 
assay time. Because of these factors and the label free characteristics of the system, the OFRR could 
potentially be used in third world countries where resources are limited. The OFRR could be used as a 
simple point-of-care device to monitor HIV progression and give doctors operating in these countries a 
tool for prognosis that exhibits CD4+ and CD8+ detection with results comparable to more expensive 
and resource heavy equipment. 
In this paper we describe the use of the OFRR for rapid identification and quantification of CD4+ 
and CD8+ T-Lymphocyte whole cells and CD4+ T-Lymphocyte cell lysis. The results show that the 
OFRR achieves accurate CD4+ and CD8+ counts at levels associated with HIV infection and the 
medically accepted levels to begin HAART and the AIDS threshold. 
2. Results and Discussion  
2.1. Detection of CD4+ T-Lymphocytes 
The OFRR was engaged for the real time detection of CD4+ T-Lymphocytes. The interior surface 
was functionalized using the procedure described in the experimental section. A detection baseline was 
created by running PBS buffer through the OFRR. Lymphocyte cell concentrations were verified using 
a hemacytometer and microscope. A level of cell viability was assessed by staining dead cells with 
Trypan Blue. It was found that in each experiment a high level of cell viability was present. After 
concentrations  of  lymphocytes  were  measured,  they  were  diluted  to  standard  concentrations  in 
medically significant ranges pertaining to individuals infected with HIV. The concentrations chosen 
were  approximately  160,  200,  250,  and  300  cells  per  µL.  The  resulting  WGM  spectral  shift  was 
recorded for each concentration and range was established based on multiple tests. Figure 2 shows one 
of the sensorgrams when CD4+ cells bind to the OFRR inner surface. During the test, sample flowing 
through the OFRR was held constant by the syringe pump at 1 µL/min. The whole test was terminated 
after approximately 30 minutes. The sensorgram exhibits much larger fluctuations in the sensing signal 
(i.e., the WGM spectral shift) than normally seen in detection of DNA or protein. This is caused by the 
non-uniform nature of cell binding processes, as compared to the binding of biomolecules. In order to 
establish  the  specificity  of  CD4+  T-Lymphocyte  binding  to  the  OFRR  sensing  region,  we  ran  a 
negative control consisting of diluted serum and red blood cells in PBS buffer. Figure 3 shows the 
resulting spectral shift ranges at varying concentrations. It is seen that the sensing signal is linearly 
dependent upon the cell concentration, although error bars are relatively large due once again to the 
nature of the cell binding. Sensors 2010, 10                                       
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Figure  2.  Sensorgram  trace  of  a  positive  control  sample  containing  approximately  
200 CD4+ cells per µL. Negative control consists of diluted serum and red blood cells.  
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Figure 3. Spectral shift recorded for various concentrations of CD4+ T-Lymphocytes in 
PBS buffer. Error bars are based on standard deviation obtained from 10 measurements. 
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2.2. Detection of CD8+ T-Lymphocyte  
Detection of CD8+ T-Lymphocytes was determined by the OFRR using a procedure similar to 
CD4+  detection.  The  OFRR  was  functionalized  using  the  procedure  outlined  in  the  experimental Sensors 2010, 10                                       
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section of this paper. Concentrations of lymphocytes were established using hemacytometer and cell 
viability was determined by staining dead cells with Trypan Blue. Cell viability was high during the 
CD8+  detection  tests.  CD8+  concentrations  were  then  prepared  replicating  probable  CD8+ 
concentrations of HIV infected individuals. The sample was pulled through the OFRR with a syringe 
pump at a rate of 1 µL/min. Multiple tests were completed to establish a range of sensing signal  
at  approximate  CD8+  concentrations.  Figure  4  shows  the  results  of  CD8+  detection  at  
various concentrations. 
Figure  4.  Spectral  shift  recorded  for  various  concentrations  of  CD8+  T-Lymphocytes. 
Error bars are based on standard deviation obtained from 10 measurements. 
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2.3. CD4 Lysis Measurements 
The OFRR was used in the detection of CD4+ T-Lymphocyte cells that were lysed. Lysing the 
whole  cells  allows  for  the  detection  of  individual  cell  surface  receptors  and  will  allow  for  more 
uniform  arrival  of  sample  to  the  sensing  area.  This  could  reduce  error  bars  and  allow  for  easier 
detection at the AIDS concentration threshold with smaller fluctuations. The OFRR was functionalized 
in the same way that was used for whole cell CD4+ T-Lymphocyte detection. Concentrations of CD4+ 
cells were established with a hemacytometer and were then lysed using a lymphocyte lysis buffer. 
Various concentrations of CD4+ cell lysis based on the CD4+ whole cell count were then passed 
through the OFRR. The concentrations tested were 180, 200, 250, 280, and 320 cells per µL. Samples 
were  pulled  through  the  OFRR  with  a  syringe  pump  at  a rate of 1 µL/  min. Multiple tests  were 
performed to establish error bars based on the standard deviation. The results of this experiment are 
shown in Figure 5. Results show that we achieve the reduction of error bars calculated from standard 
deviation at the same concentrations used in CD4+ whole cell detection. Sensors 2010, 10                                       
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Figure  5.  Spectral shift recorded for concentrations of CD4+ T-Lymphocyte cell lysis. 
Error bars are based on standard deviation obtained from 5 measurements. 
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3. Experimental 
3.1. Materials 
Ninety-eight  percents  Ethanol,  47%  hydrofluoric  acid  (HF),  3-aminopropyltrimethoxysilane  
(3-APS), Trypan Blue, and recombinant protein G were purchased from Sigma-Aldrich (St. Louis, 
MO).  Dimethyl  pimelimidate  dihydrochloride  (DMP)  cross  linker  was  purchased  from  Pierce 
Biotechnology (Rockford, IL). Lysis buffer consisting of Tris-HCL, Triton X-100, MgCl2, and sucrose 
used materials obtained from Sigma Aldrich. CD4 mouse monoclonal IgG antibodies were purchased 
from  Santa  Cruz  Biotechnology  (Santa  Cruz,  CA)  and  CD8  mouse  monoclonal  antibodies  were 
purchased from AbCam (Cambridge, MA). White blood cells were isolated from whole blood drawn at 
Ellis Fischel Cancer Center (Columbia, MO). Concentrations of lymphocytes were verified using a 
hemacytometer in lab purchased from Sigma-Aldrich. Silica glass tubes of 1.2 mm outer diameter  
and 0.85 mm inner diameter were purchased from Sutter Instruments (Novato, CA).  
3.2. Experimental Setup 
The OFRR was fabricated by pulling a quartz tube under intense heat generated by two CO2 lasers 
creating a capillary with a 150 µm outside diameter. In order to increase the sensitivity of the OFRR to 
achieve biomolecule detection, the wall thickness was reduced to a few micrometers with a diluted 
solution of HF. Solutions were passed through the OFRR with a syringe pump. These procedures have 
been described in detail in previous publications [16,22]. A schematic of the experimental setup is 
shown in Figure 1. The tapered optic fiber with a diameter of approximately 3.5 µm was created by 
pulling SMF-28 optical fiber under heat. This tapered optical fiber was brought into contact with the Sensors 2010, 10                                       
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OFRR to couple light from a 1,550 nm tunable diode laser from Philips (San Jose, California) into the 
ring resonator. The laser was scanned at a rate of 0.5 Hz. A photodetector was used to monitor the 
intensity of light emitted from the end of the tapered fiber cable. When the scanning laser wavelength 
matches the resonant wavelength, a dip in intensity was observed at the photodetector with a minimum 
corresponding to the WGM spectral position. This dip in intensity could be used as a sensing signal 
because  the  spectral  position  of  the  WGM  can  be  tracked  in  real  time.  The  light  intensity 
measurements were recorded as a voltage using a computer and a data acquisition card from National 
Instruments (Austin, TX). A LabView interface is used to control the data acquisition rate and laser 
scanning. The spectral position of the WGM was recorded in real time for post-experiment analysis.  
3.3. Bulk Refractive Index Sensitivity (BRIS) Characterization of the OFRR  
The OFRR utilizes the RI change near the surface of the sensing wall to detect biomolecules. The 
spectral shift in response to bulk RI changes in the capillary is known as the bulk RI sensitivity (BRIS). 
In order to establish a relationship between biomolecule buildup and spectral shift, we must establish a 
bulk sensitivity of the OFRR in units of nm RIU
−1. First, different concentrations of ethanol in water 
were run through the OFRR. These solutions had known RI and the resulting shift was recorded for 
analysis. The increase of RI in these solutions resulted in a larger spectral shift. Fitting the data points 
with a trend line, we can find that the sensitivity of the OFRR used in our experiments was around  
21.9 nm RIU
−1. Figure 6 shows the characterization curve obtained from the BRIS test.  
Figure 6. OFRR sensitivity curve with BRIS of 21.9 nm RIU
−1. 
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3.4. Functionalization of the OFRR Inner Surface 
In  order  to  specifically  capture  biomolecules,  surface  functionalization  has  to  be  precisely 
controlled. In this study, antibodies were immobilized on the inner surface of the OFRR to specifically Sensors 2010, 10                                       
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interact with CD4+ and CD8+ receptors located on lymphocytes. First, the surface of the OFRR was 
charged  by  passing  a  very  low  concentration  of  HF  (2%)  followed  by  ethanol  through  the  inner 
capillary. Next, a 4% solution of 3-APS in 10% ethanol was passed through the OFRR for 20 minutes 
to silanize the surface. After rinsing with 10% ethanol, 30 mg of DMP was dissolved in 20 µL of PBS 
and  used  to  cross  link  protein  G  to  the  surface.  Protein  G  was  passed  through  the  OFRR  in  
a 1 mg mL
−1 of PBS concentration. Protein G serves to orient the antibodies in a way that maximizes 
the efficiency of receptor interaction. Excess and unbound protein G was rinsed using PBS and then 
CD4+ or CD8+ antibodies were then pulled through the OFRR.  
3.5. CD4+ and CD8+ Cell Capture Measurements 
After surface functionalization, the OFRR was rinsed with PBS buffer and prepared for CD4+ and 
CD8+ measurements. White blood cells were isolated from healthy whole blood using a centrifuge. 
The concentrations of white blood cells were verified using a hemacytometer then adjusted to match 
CD4+ and CD8+ concentrations of HIV infected individuals. Targeted to the receptors were CD4+ and 
CD8+ antibodies immobilized in the microfluidic channel of the OFRR. The lymphocyte cells were 
prepared in PBS buffer at varying concentrations. In each measurement, concentrations of lymphocytes 
in PBS were passed through the OFRR followed by a PBS rinse to remove unbound cells from the 
OFRR surface. Anti-CD4 antibody is specific to the CD4+ receptor located on CD4+ Lymphocyte  
T-helper cells. Anti-CD8 antibody is specific to the CD8+ Cytotoxic T-cells. After each measurement 
cycle, the OFRR was cleaned with a 2% solution of HF to completely remove all of the functional and 
biomolecule layers for the surface. After washing, the OFRR can be prepped for the next measurement. 
The  WGM  spectral  position  was  recorded  and  monitored  in  real  time  during  
the  buildup  of  functional  layers  and  receptor  measurements.  This  data  was  utilized  for  
post-experiment analysis. 
4. Conclusions 
In this work, we have developed label free, rapid, and sensitive optical sensor for use in the whole 
cell  detection  of  CD4+  and  CD8+  T-Lymphocytes,  and  CD4+  cell  lysis  detection.  We  show 
distinguishable detection ranges around and below 200 CD4+ cells per µL and up to 320 CD4+ cells 
per µL. We also show a detection range of CD8+ cells from 250 to over 1,000 cells per µL. The 
concentrations used are at medically significant levels and are comparable with high tier standardized 
equipment such as flow cytometers. This work could lead to a cost-effective and easy to use device that 
can  be  utilized  in  the  field  to  give  an  accurate  description  of  HIV  progression  in  resource  
limited regions. 
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